Brief: Taysha Gene Therapies Inc Shares Open 11.3% Above IPO Price In Debut on Nasdaq
24/09/2020 16:25
Sept 24 (Reuters) -
* TAYSHA GENE THERAPIES INC SHARES OPEN AT $22.25 IN DEBUT
ON
NASDAQ VERSUS IPO PRICE OF $20.00/SHARE
Further company coverage: TSHA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Taysha Gene Therapies
See all newsUniqure jumps after FDA vaccines chief Vinay Prasad to step down
US FDA names agency critic Vinay Prasad as top vaccine official (updated)
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
US FDA names oncologist Vinay Prasad as top vaccine official (updated)